The U.S. Supreme Court on Friday told the Fourth and Eleventh circuits to revisit closely watched whistleblower cases targeting units of Allergan and Abbott Laboratories, teeing up tests of the high court's new ruling on the meaning of intentional fraud under the False Claims Act.
Against long odds, two doctors facing decades in prison implored the U.S. Supreme Court to harmonize jury instructions in opioid crisis prosecutions, insisting that innocence in one circuit could be guilt in another. They ultimately prevailed, but one year later, the circuit split surprisingly appears even starker, as one of the doctors eyes freedom, and the other still might live out his life behind bars.
The nation's biggest law firms have espoused "a very extreme, pro-abortion viewpoint" during the saga surrounding the U.S. Supreme Court's seismic rejection of abortion rights, putting themselves at odds with constitutional law and their own workforces, a top attorney at a major legal group waging anti-abortion litigation told Law360.
The U.S. Supreme Court's ruling that faulty yet reasonable compliance views can trigger False Claims Act liability is undermining defense bar positions in wide-ranging contexts, including a new circuit split over FCA cases involving kickbacks, according to the U.S. Department of Justice.
Pharmaceutical giant Merck picked the first legal fight over landmark legislation letting Medicare negotiate drug prices, and the company showed up with bare-knuckle rhetoric and a Jones Day partner who told Law360 on Tuesday that the litigation "fits perfectly" into his mission of battling Uncle Sam's excesses.